BTHE
$0.02
Boston Therapeutics
$.00
12.07%
BTHE
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Oct 25
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BTHE reports earnings?
Beat
Meet
Miss

Where is BTHE's stock price going from here?
Up
Flat
Down
Stock chart of BTHE
Analysts
Summary of analysts' recommendations for BTHE
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Boston Therapeutics, Inc. is a pharmaceutical company engaged in the development, manufacturing, and commercialization of compounds for the treatment of diabetes and inflammatory diseases. The Company focuses on glyco-pathology. Its product portfolio includes SUGARDOWN(R), PAZ320 and IPOXYN(TM). Boston Therapeutics, Inc. is based in Manchester, New Hampshire.
Peers
Vertex PharmaceuticalsUltragenyx PharmaceuticalRegeneron PharmaceuticalsBioMarin PharmaceuticalBristol-Myers SquibbInterCeptMerck & Co.Eli LillyZoetisPfizer